News Letter to Shareholders and Corporate Update Continue Reading Previous Sandoz announces exclusive deal to commercialize biosimilar ustekinumab, further reinforcing growing pipeline and immunology patient offeringNext Verona Pharma Announces the US FDA has Accepted the New Drug Application Filing for Ensifentrine for the Maintenance Treatment of COPD Related Stories News Buy International Homes at the Global Property Expo, Singapore News Dr. Wonder Clinic Celebrates Major Milestone in Global Oral Health Advocacy with New Prevention Program News my mimi Strengthens Menstrual Education with Enhanced Learning Platform News Interact Direct Holdings Limited Files Late Early Warning Report News Universal Digital Acquires 10 Bitcoin in First Treasury Allocation News Gorilla Provides Business Updates
